Pharma Co. Behind Fentanyl Spray Seeks Out Of Investor Suit
Specialty pharmaceutical company Insys Therapeutics Inc. has urged a New York federal court to toss a proposed class action accusing it of seeking to cover up declining revenues from its fentanyl-based...To view the full article, register now.
Already a subscriber? Click here to view full article